James Laird, MD
Assistant Professor of Therapeutic RadiologyCards
About
Research
Publications
2023
Radiation Pneumonitis
Laird J, Decker R, Roberts K, Park H. Radiation Pneumonitis. In: Grippi M, Antin-Ozerkis D, Dela Cruz C, Kotloff R, Kotton C, Pack A (editors). Fishman’s Pulmonary Diseases and Disorders, 6th edition. New York: McGraw-Hill: 2023; p. 966-986.Chapters
2022
Early Laryngeal Cancer
Crosby T, Laird J, Park H, McWharter A. Early Laryngeal Cancer. In: Johnson J and Rosen C (editors). Bailey’s Head & Neck Surgery Otolaryngology, 6th Edition. Philadelphia: LWW: 2022; Chapter 141.Chapters
2021
Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer
Laird J, Leventhal J, Kanowitz J, Damast S. Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer. Practical Radiation Oncology 2021, 11: 448-452. PMID: 34157449, DOI: 10.1016/j.prro.2021.06.001.Peer-Reviewed Original ResearchDrivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties
Mokhtech M, Laird JH, Maroongroge S, Zhu D, Falit B, Johnstone PAS, Mantz CA, Ennis RD, Sandler HM, Dosoretz AP, Yu JB. Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties. International Journal Of Radiation Oncology • Biology • Physics 2021, 110: 322-327. PMID: 33412264, DOI: 10.1016/j.ijrobp.2020.12.051.Peer-Reviewed Original Research
2020
Ovarian Cancer
Laird J, Tymon-Rosario J, Damast S. Ovarian Cancer. 2020 DOI: 10.1891/9780826155146.0026.ChaptersEndometrial Cancer
Laird J, An Y, Damast S. Endometrial Cancer. 2020 DOI: 10.1891/9780826155146.0027.ChaptersCervical Cancer
Laird J, Young M, Damast S. Cervical Cancer. 2020 DOI: 10.1891/9780826155146.0028.ChaptersVulvar Cancer
Laird J, Young M, Damast S. Vulvar Cancer. 2020 DOI: 10.1891/9780826155146.0030.Chapters
2019
Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts
Laird J, Lok B, Carney B, Kossatz S, de Stanchina E, Reiner T, Poirier J, Rudin C. Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts. Journal Of Thoracic Oncology 2019, 14: 1743-1752. PMID: 31195178, PMCID: PMC6764879, DOI: 10.1016/j.jtho.2019.05.032.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsApoptosisCell ProliferationFemaleFluorine RadioisotopesHumansLung NeoplasmsMiceMice, Inbred NODMice, SCIDPhthalazinesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPositron-Emission TomographyRadiopharmaceuticalsSmall Cell Lung CarcinomaTumor Cells, CulturedXenograft Model Antitumor AssaysConceptsPatient-derived xenograftsPositron emission tomographicPARP inhibitorsTherapeutic efficacyTarget engagementPositron emission tomographic imagingDifferential therapeutic efficacyTumor radiotracer uptakeTumor growth inhibitionEnzyme-linked immunosorbentDose-dependent mannerFluorine-18Oral talazoparibMultiple dosesSingle dosesTotal tumorsPolymerase-1 (PARP-1) inhibitorsPET uptakeRadiotracer uptakeInhibitor of polyIndividual tumorsPET/Drug efficacyTalazoparib treatmentPromising therapeutics
Clinical Care
Overview
James Laird, MD, is a therapeutic radiologist who specializes in treating thoracic, head and neck, gastrointestinal, skin, and gynecologic cancers. Dr. Laird uses advanced radiotherapy techniques to manage these conditions, focusing on providing personalized care to his patients.
Dr. Laird feels a deep connection to cancer patients, influenced by his own family's experiences with the disease. "It is an honor to be able to help patients and be part of their lives as they battle cancer," he says.
As an assistant professor of therapeutic radiology at Yale School of Medicine, Dr. Laird's research interests include exploring the role of local treatments in oligometastatic cancer, aiming to improve patient outcomes.
Dr. Laird received his medical training from New York University School of Medicine. He completed his residency in radiation oncology at Yale School of Medicine.
Clinical Specialties
Fact Sheets
Throat Cancer
Learn More on Yale MedicineMetastatic Cancer
Learn More on Yale MedicineNon-Small Cell Lung Cancer
Learn More on Yale MedicineRadiofrequency Ablation (RFA)
Learn More on Yale Medicine
Yale Medicine News
Get In Touch
Contacts
Therapeutic Radiology
P.O. Box 208040
New Haven, CT 06520-8040
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
- Everyone
- Everyone